GBIO vs STTK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 20, 2026

GBIO

42.9
AI Score
VS
STTK Wins

STTK

53.0
AI Score

Investment Advisor Scores

GBIO

43score
Recommendation
HOLD

STTK

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric GBIO STTK Winner
Forward P/E 7.874 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -78.9% -66.6% STTK
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 42.9/100 53.0/100 STTK
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

GBIO 1M: -2.4% · 3M: +1.7% STTK 1M: -9.2% · 3M: -7.9%

Current Technical Phase

GBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 39.7 · Price: $5.34

STTK

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.6 · Price: $6.40

Fundamentals Snapshot

Metric GBIO STTK
Market Cap — —
Forward P/E -0.7 -12.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.8% -0.7%
Gross Margin -2.1% -38.2%
Operating Margin -20.2% -55.7%
EPS -9.37 -0.44
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, STTK is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.